Clinical Trial Update: Improve the Treatment of Thoracic Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for thoracic esophageal squamous cell carcinoma, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Thoracic Esophageal Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED